Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Latest filing published 29 Aug 2025 for iTeos Therapeutics, Inc..
Filing timeline
BuySaleMatthew Gall
Insider track record
Disclosed buys
3
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Matthew Gall: trading record in brief
Matthew Gall discloses dealings in iTeos Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 16 June 2021 to 29 August 2025, the count stands at 8 filings.
On the open market, the record shows 3 purchases worth €185k and 1 sale worth €205k. Sales outweigh purchases by €20k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants and 1 option exercise.
In size, the median ticket on the buying side is €40k. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 29 August 2025: a transaction, in iTeos Therapeutics, Inc. The last insider purchase was made public on 19 November 2024, 704 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew Gall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
89,429 sharesCommon StockSEC:0000950170-25-112236:0
24,000 shares0Common StockSEC:0000950170-25-037512:0
5,000 shares@ US$7.7274.3% of flowCommon StockSEC:0000950170-24-128956:0
Canonical exit: 17 Feb 2025 (T+90)
41,000 shares0Common StockSEC:0000950170-23-068901:0
5,000 shares@ US$8.374.6% of flowCommon StockSEC:0001209191-23-052709:0
Canonical exit: 10 Jan 2024 (T+90)
5,000 shares@ US$46.4543.9% of flowCommon StockSEC:0001209191-21-071435:0
14,429 shares@ US$6.1616.5% of flowCommon StockSEC:0001209191-21-060297:0
5,000 shares@ US$26.089323.3% of flowCommon StockSEC:0000899243-21-024236:0
Canonical exit: 14 Sept 2021 (T+90)
8 of 8 declarations
